Medication Access Is Becoming an Enterprise Workflow Layer
Automation is moving medication access from a narrow admin task into a core enterprise layer that determines whether prescriptions become filled therapies.
What is this trend?
Medication access is shifting from a back-office prior authorization task into an enterprise workflow layer that automates the path from prescription to dispensed therapy.
- Automation now spans prior auth, appeals, financial aid, and pharmacy routing.
- The value is in converting written prescriptions into filled prescriptions at scale.
- Specialty-specific integrations are becoming a key competitive moat.
- Medication access is emerging as infrastructure, not a point solution.
- Enterprise buyers want workflow tools tied to revenue realization and patient conversion.
What’s the latest?
Forus raised a $150 million Series C led by Bain Capital Ventures at a $3 billion valuation, reportedly tripling its value in about four months and lifting total funding above $300 million.
How it developed
- Workflow-Embedded AI Execution, Operational Interoperability, Platform M&A, and Outcome-Backed Hybrid Care
- Outcome-Backed Hybrid Care Is Winning Capital
Go deeper
Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.
If you operate in this industry
If you sell into this industry
From 300-Page Packets to 30: How AI Is Changing Payer-Nursing Home Relationships, Simplifying Reviews and Speeding Referrals
News analysis interview with Mark Lilly and Justin Meara on AI speeding nursing-home referrals and payer trust.
Skilled Nursing News · News
Read →GLP-1 costs are forcing HR leaders to rethink drug benefits
News analysis interview with Chris Byrd on GLP-1 benefit shifts to HRAs as enterprise workflow layer.
Human Resources Director · News
Read →If you invest in this industry

Emerging Market Landscape for Automated Medical Necessity Decisions
Trends piece on payer/provider AI automating denials, appeals, and 2027 API rules reshaping med access workflows.
Thoughts on Healthcare Markets & Technology · Substack
Read →4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds
News analysis spotlighting outpatient/home healthcare stocks as digital hybrid care and value-based models attract capital.
TradingView · News
Read →
NuvemRx: Interview With CEO Scott Seidelmann About Technology-Enabled 340B Pharmacy Services
Interview with CEO Scott Seidelmann on tech-enabled 340B pharmacy services consolidating access into an enterprise workflow layer.
Pulse 2.0 · News
Read →